Laura D. Hover

980 total citations
16 papers, 270 citations indexed

About

Laura D. Hover is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Laura D. Hover has authored 16 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Genetics and 5 papers in Oncology. Recurrent topics in Laura D. Hover's work include Glioma Diagnosis and Treatment (6 papers), TGF-β signaling in diseases (5 papers) and Cancer Cells and Metastasis (3 papers). Laura D. Hover is often cited by papers focused on Glioma Diagnosis and Treatment (6 papers), TGF-β signaling in diseases (5 papers) and Cancer Cells and Metastasis (3 papers). Laura D. Hover collaborates with scholars based in United States and Spain. Laura D. Hover's co-authors include Philip Owens, Harold L. Moses, Sergey V. Novitskiy, Agnieszka E. Gorska, Michael W. Pickup, Anna Chytil, Charles C. Hong, Ty W. Abel, James C. Fleet and Yan Guo and has published in prestigious journals such as Cancer Research, Journal of Hepatology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Laura D. Hover

14 papers receiving 270 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura D. Hover United States 8 172 90 86 45 38 16 270
Hongling Yuan China 7 250 1.5× 79 0.9× 136 1.6× 18 0.4× 31 0.8× 20 333
Alison D. Clark United States 5 196 1.1× 50 0.6× 92 1.1× 18 0.4× 38 1.0× 5 370
Sandra Di Gregorio Italy 10 108 0.6× 41 0.5× 66 0.8× 101 2.2× 28 0.7× 17 323
Yingnan Wang China 9 102 0.6× 78 0.9× 157 1.8× 37 0.8× 30 0.8× 22 298
Kristin E. Hunt United States 7 240 1.4× 79 0.9× 101 1.2× 52 1.2× 150 3.9× 11 428
Jianghua Qiao China 12 155 0.9× 131 1.5× 120 1.4× 11 0.2× 26 0.7× 30 320
Andrzej Tysarowski Poland 11 145 0.8× 53 0.6× 117 1.4× 16 0.4× 25 0.7× 36 315
Martin Kirschner Germany 13 196 1.1× 29 0.3× 87 1.0× 105 2.3× 28 0.7× 33 389
Mohammad Daremipouran United States 8 176 1.0× 114 1.3× 108 1.3× 21 0.5× 123 3.2× 16 341
A Koch Germany 8 180 1.0× 96 1.1× 80 0.9× 20 0.4× 38 1.0× 11 339

Countries citing papers authored by Laura D. Hover

Since Specialization
Citations

This map shows the geographic impact of Laura D. Hover's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura D. Hover with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura D. Hover more than expected).

Fields of papers citing papers by Laura D. Hover

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura D. Hover. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura D. Hover. The network helps show where Laura D. Hover may publish in the future.

Co-authorship network of co-authors of Laura D. Hover

This figure shows the co-authorship network connecting the top 25 collaborators of Laura D. Hover. A scholar is included among the top collaborators of Laura D. Hover based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura D. Hover. Laura D. Hover is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Negrão, Marcelo V., David Molkentine, Laura D. Hover, et al.. (2024). Abstract 1212: Impact of KEAP1/STK11 co-mutations and NRF2 signaling on resistance to adagrasib in advanced NSCLC. Cancer Research. 84(6_Supplement). 1212–1212.
3.
Hoffman, Natalie, Andrew Calinisan, David M. Briere, et al.. (2024). Abstract 4448: Effects of adagrasib on cholesterol, lipid and glucose gene expression regulation in tumor xenograft models and patient samples. Cancer Research. 84(6_Supplement). 4448–4448. 1 indexed citations
4.
Waters, Laura, Ruth Aranda, Krystal Moya, et al.. (2023). Abstract 2779: Identification of mechanism-based combination targets effective with the MTA-cooperative PRMT5 inhibitor MRTX1719 for the treatment of MTAP deleted cancers. Cancer Research. 83(7_Supplement). 2779–2779. 1 indexed citations
5.
Hover, Laura D., Xiaoyan Zhu, David J. Goldhamer, et al.. (2020). DIPG-51. ACVR1 MUTATIONS PROMOTE TUMOR GROWTH IN MODELS OF DIFFUSE INTRINSIC PONTINE GLIOMA. Neuro-Oncology. 22(Supplement_3). iii296–iii297. 1 indexed citations
6.
Tinkle, Christopher L., Brittany A. Simone, Jason Chiang, et al.. (2019). Defining Optimal Target Volumes of Conformal Radiation Therapy for Diffuse Intrinsic Pontine Glioma. International Journal of Radiation Oncology*Biology*Physics. 106(4). 838–847. 9 indexed citations
7.
Xu, Ke, Liang Ding, Ti‐Cheng Chang, et al.. (2018). Structure and evolution of double minutes in diagnosis and relapse brain tumors. Acta Neuropathologica. 137(1). 123–137. 59 indexed citations
8.
Hover, Laura D., et al.. (2017). TMOD-07. NTRK3 GENE FUSIONS DRIVE TUMORIGENESIS IN NOVEL MODELS OF PEDIATRIC HIGH GRADE GLIOMA. Neuro-Oncology. 19(suppl_4). iv49–iv50. 1 indexed citations
9.
Hover, Laura D., Philip Owens, Jialiang Wang, et al.. (2015). Bone morphogenetic protein signaling promotes tumorigenesis in a murine model of high-grade glioma. Neuro-Oncology. 18(7). 928–938. 26 indexed citations
10.
Hover, Laura D., Christian D. Young, Neil E. Bhola, et al.. (2015). Small molecule inhibitor of the bone morphogenetic protein pathway DMH1 reduces ovarian cancer cell growth. Cancer Letters. 368(1). 79–87. 32 indexed citations
11.
Pickup, Michael W., Laura D. Hover, Yan Guo, et al.. (2015). Deletion of the BMP receptor BMPR1a impairs mammary tumor formation and metastasis. Oncotarget. 6(26). 22890–22904. 39 indexed citations
12.
Hover, Laura D., Michael W. Pickup, Agnieszka E. Gorska, et al.. (2015). Abstract 4083: Deletion of the BMP receptor BMPR1a results in EMT and impairs mammary gland tumor formation and metastasis. Cancer Research. 75(15_Supplement). 4083–4083. 1 indexed citations
13.
Hover, Laura D., Ty W. Abel, & Philip Owens. (2015). Genomic Analysis of the BMP Family in Glioblastomas. PubMed. 7. 1–9. 5 indexed citations
14.
Pickup, Michael W., Laura D. Hover, Anna Chytil, et al.. (2014). BMPR2 loss in fibroblasts promotes mammary carcinoma metastasis via increased inflammation. Molecular Oncology. 9(1). 179–191. 30 indexed citations
15.
Zhao, Zhiguo, et al.. (2012). Cell of Origin Determines Tumor Phenotype in an Oncogenic Ras/p53 Knockout Transgenic Model of High-Grade Glioma. Journal of Neuropathology & Experimental Neurology. 71(8). 729–740. 20 indexed citations
16.
Maund, Sophia L., Wendy W. Barclay, Laura D. Hover, et al.. (2011). Interleukin-1α Mediates the Antiproliferative Effects of 1,25-Dihydroxyvitamin D3 in Prostate Progenitor/Stem Cells. Cancer Research. 71(15). 5276–5286. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026